UC1010

Umecrine Mood AB · Phase 1 active Small molecule

At a glance

Generic name	UC1010
Sponsor	Umecrine Mood AB
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine (PHASE2)
A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) (PHASE2)
A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

UC1010 CI brief — competitive landscape report
UC1010 updates RSS · CI watch RSS
Umecrine Mood AB portfolio CI